Long-standing mystery about mRNAs resolved

A new Weill Cornell Medicine study solves a 50-year mystery and suggests that faulty mRNA modification may underlie some autoimmune and inflammatory disorders.

Cross-campus center tackles antimicrobial resistance

A new center at Cornell will fight the rise of antibiotic resistance, a global health challenge that threatens to reverse critical advances in modern medicine.

Twelve faculty members elected AAAS fellows

Twelve Cornell and Weill Cornell Medicine faculty members – six of whom are also Cornell alumni – have been elected fellows of the American Association for the Advancement of Science, the world’s largest general scientific society.

‘Racial uplifts’ aid Asian American well-being

Positive everyday racial encounters may increase self-esteem and help counteract negative experiences from discrimination, according to new Cornell psychology research.

Study shows how cells prevent harmful extra DNA copies

A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers. 

Travel worsens poor conditions for rural health aides

Rural health care workers face challenges tied primarily to long commutes, exacerbating poor working conditions in the home care industry.

Physician and health care reform expert to lead discussion

Prominent physician, author and health services researcher Martin Shapiro will speak at an event on the Ithaca campus. He will describe steps to reform the health care system and lead a discussion that is open to all.

Around Cornell

Lymphoma mutation yields super-competitive immune cells

The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, according to a multi-institutional preclinical study led by Weill Cornell Medicine investigators.

Scientists detail major mechanism lung cancers use to evade immune attack

A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine.